172 related articles for article (PubMed ID: 22246783)
1. Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells.
Zha L; Wang Z; Tang W; Zhang N; Liao G; Huang Z
Mol Cell Biochem; 2012 May; 364(1-2):243-51. PubMed ID: 22246783
[TBL] [Abstract][Full Text] [Related]
2. HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
Zha L; Zhang J; Tang W; Zhang N; He M; Guo Y; Wang Z
Dig Dis Sci; 2013 Mar; 58(3):724-33. PubMed ID: 23135750
[TBL] [Abstract][Full Text] [Related]
3. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
4. HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
Li W; Wang Z; Zha L; Kong D; Liao G; Li H
Oncol Rep; 2017 Jan; 37(1):185-192. PubMed ID: 27878307
[TBL] [Abstract][Full Text] [Related]
5. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
6. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
7. Effects of HMGA2 on the biological characteristics and stemness acquisition of gastric cancer cells.
Kong D; Zha L; Yao Y; Zhang Z; Gao J; Zhang R; Chen L; Wang Z
Arab J Gastroenterol; 2024 May; 25(2):135-142. PubMed ID: 38378354
[TBL] [Abstract][Full Text] [Related]
8. HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer.
Dong J; Wang R; Ren G; Li X; Wang J; Sun Y; Liang J; Nie Y; Wu K; Feng B; Shang Y; Fan D
Clin Cancer Res; 2017 Jul; 23(13):3461-3473. PubMed ID: 28119367
[No Abstract] [Full Text] [Related]
9. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
[TBL] [Abstract][Full Text] [Related]
10. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
13. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.
Thuault S; Tan EJ; Peinado H; Cano A; Heldin CH; Moustakas A
J Biol Chem; 2008 Nov; 283(48):33437-46. PubMed ID: 18832382
[TBL] [Abstract][Full Text] [Related]
14. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
15. Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition.
Tan EJ; Thuault S; Caja L; Carletti T; Heldin CH; Moustakas A
J Biol Chem; 2012 Mar; 287(10):7134-45. PubMed ID: 22241470
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Kong D; Su G; Zha L; Zhang H; Xiang J; Xu W; Tang Y; Wang Z
Med Oncol; 2014 Aug; 31(8):130. PubMed ID: 25037576
[TBL] [Abstract][Full Text] [Related]
18. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer.
Mansoori B; Mohammadi A; Naghizadeh S; Gjerstorff M; Shanehbandi D; Shirjang S; Najafi S; Holmskov U; Khaze V; Duijf PHG; Baradaran B
J Cell Physiol; 2020 Feb; 235(2):920-931. PubMed ID: 31241772
[TBL] [Abstract][Full Text] [Related]
19. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma.
Zhu M; Zhang C; Chen D; Chen S; Zheng H
Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
